Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,739.77
(
-0.02%
)
News Focus
News Focus
Post# of 257661
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: biomaven0 post# 137693

Thursday, 02/23/2012 10:23:31 PM

Thursday, February 23, 2012 10:23:31 PM

Post# of 257661

I personally didn't see anything troubling about the safety data at all except for the known cleft issue.





There were two Qnexa patients that had heart attacks and a high rate of non-responders (25%?) which draws attention to the risk benefit of premature approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today